chr2-47369506-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1_StrongPS1_ModeratePM2PP5_Very_Strong
The NM_002354.3(EPCAM):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,549,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002354.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000133 AC: 2AN: 150630Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83022
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1397758Hom.: 0 Cov.: 31 AF XY: 0.0000159 AC XY: 11AN XY: 690930
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
Gastric cancer Pathogenic:1
- -
EPCAM-related disorder Pathogenic:1
The EPCAM c.1A>G variant is predicted to disrupt the translation initiation site (Start loss). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0045% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-47596645-A-G). Other predicted loss-of-function variants have been reported nearby (see, for example, Cheema et al. 2020. PubMed ID: 33083013; Zhu et al. 2020. PubMed ID: 33240318). This variant is interpreted as likely pathogenic. -
Familial cancer of breast Pathogenic:1
The EPCAM c.1A>G variant is predicted to disrupt the translation initiation site (Start loss) and loss-of-function is a known mechanism of disease . This variant has not been reported in the literature. This Variant not found in gnomAD. In silico prediction tools (PolyPhen, SIFT , M-CAP , CADD ,MetaRNN, BayesDel addAF and MutPred ) support its disease causing variant . Therefore, it has been classified as likely pathogenic variant . Pathogenic/likely pathogenic heterozygous variants in the EPCAM gene cause autosomal dominant Lynch syndrome 8 (OMIM # 613244) which has Incomplete penetrance -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at